In vitro activity of midecamycin, a new macrolide antibiotic.
AUTOR(ES)
Neu, H C
RESUMO
Midecamycin, an acetoxy-substituted macrolide antibiotic, was tested against gram-positive and gram-negative bacteria. It inhibited the majority of streptococci, staphylococci, and strains of Haemophilus and Listeria at concentrations of less than 3.1 micrograms/ml. It was less active than erythromycin, and it failed to inhibit erythromycin-resistant isolates.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=185343Documentos Relacionados
- Maridomycin, a New Macrolide Antibiotic. In Vitro Antibacterial Activity of 9-Propionylmaridomycin
- In vitro antibacterial activity of faeriefungin, a new broad-spectrum polyene macrolide antibiotic.
- Comparative in vitro activity of CGP 31608, a new penem antibiotic.
- In vitro antibacterial activity of KP-736, a new cephem antibiotic.
- In vitro activity of SK&F 104662, a new glycopeptide antibiotic.
